Shreya Acquisition Group Form 8-K Summary
Business Context and Reporting Period
Shreya Acquisition Group, a Cayman Islands-based emerging growth company, filed this Current Report on Form 8-K on May 8, 2026. The filing documents the consummation of its Initial Public Offering (IPO) and a concurrent private placement. The company is incorporated in the Cayman Islands with principal executive offices in New York, New York.
Key Financial Metrics
- Gross Proceeds from IPO: $110,000,000 from the sale of 11,000,000 Units at $10.00 per Unit.
- Gross Proceeds from Private Placement: $1,917,500 from the sale of 191,750 Private Units to the Sponsor at $10.00 per Unit.
- Total Capital Raised: $111,917,500.
- Warrant Exercise Price: $11.50 per share (subject to adjustment).
- Debt and Liquidity: The filing text does not provide specific debt figures or liquidity ratios; however, an audited balance sheet reflecting the receipt of proceeds is included as Exhibit 99.1.
- Revenue and Profit: Not applicable for this pre-business combination SPAC filing; no operating revenue or profit is reported.
Material Changes
The primary material change is the transition from a private entity to a publicly traded company on the New York Stock Exchange. The company issued 11,000,000 Units, which included a partial exercise of the over-allotment option for 1,000,000 additional Units. No incremental underwriting expenses were incurred for the over-allotment portion.
Outlook, Risks, and Unusual Items
The company is now obligated to consummate an initial business combination. Upon such consummation, Rights included in the Units will entitle holders to receive one-fourth of one Class A ordinary share. The filing notes that the company is an emerging growth company. No specific risks or contingencies beyond standard SPAC operational requirements are detailed in the text of this summary.
Investor Verification Checklist
- Verify the final audited balance sheet in Exhibit 99.1 to confirm cash balances and any immediate liabilities.
- Confirm the exact number of shares outstanding post-IPO, including the impact of the over-allotment.
- Review the underwriting agreement to understand deferred underwriting commissions, if any, which are not explicitly detailed in this text.
- Monitor the timeline for the initial business combination as required by the company's charter.